Royal Prince Alfred Hospital
Christopher is a molecular cardiologist with a strong research interest in genetic heart disorders, with a particular focus on sudden cardiac death in the young. After completing his medical and cardiology training at Royal Prince Alfred Hospital in Sydney, he undertook a highly successful PhD at the Victor Chang Cardiac Research Institute. Christopher continued his research in the Department of Genetics at Harvard Medical School, Boston. The ultimate goal of Christopher’s research is to understand how abnormalities in our genetic make-up lead to heart diseases, and by doing so, to be able to develop novel therapeutic strategies to both prevent and cure these heart disorders and their complications such as sudden death.